scPharmaceuticals Inc. Quarterly Current Ratio in % from Q3 2018 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
scPharmaceuticals Inc. quarterly Current Ratio history and growth rate from Q3 2018 to Q3 2024.
  • scPharmaceuticals Inc. Current Ratio for the quarter ending September 30, 2024 was 663 %, a 53.6% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 663 -767 -53.6% Sep 30, 2024
Q2 2024 682 -372 -35.3% Jun 30, 2024
Q1 2024 900 +158 +21.4% Mar 31, 2024
Q4 2023 1.14K +592 +108% Dec 31, 2023
Q3 2023 1.43K +1.02K +251% Sep 30, 2023
Q2 2023 1.05K +559 +113% Jun 30, 2023
Q1 2023 742 +151 +25.6% Mar 31, 2023
Q4 2022 546 -158 -22.5% Dec 31, 2022
Q3 2022 407 -449 -52.4% Sep 30, 2022
Q2 2022 495 -596 -54.6% Jun 30, 2022
Q1 2022 591 -796 -57.4% Mar 31, 2022
Q4 2021 704 -864 -55.1% Dec 31, 2021
Q3 2021 856 -850 -49.8% Sep 30, 2021
Q2 2021 1.09K -422 -27.9% Jun 30, 2021
Q1 2021 1.39K +368 +36.1% Mar 31, 2021
Q4 2020 1.57K +681 +76.7% Dec 31, 2020
Q3 2020 1.71K +810 +90.3% Sep 30, 2020
Q2 2020 1.51K +569 +60.2% Jun 30, 2020
Q1 2020 1.02K -173 -14.5% Mar 31, 2020
Q4 2019 888 -586 -39.8% Dec 31, 2019
Q3 2019 897 -768 -46.1% Sep 30, 2019
Q2 2019 944 Jun 30, 2019
Q1 2019 1.19K Mar 31, 2019
Q4 2018 1.47K Dec 31, 2018
Q3 2018 1.66K Sep 30, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.